Myriad Genetics Balance Sheet Health
Financial Health criteria checks 4/6
Myriad Genetics has a total shareholder equity of $760.0M and total debt of $38.7M, which brings its debt-to-equity ratio to 5.1%. Its total assets and total liabilities are $1.1B and $350.5M respectively.
Key information
5.1%
Debt to equity ratio
US$38.70m
Debt
| Interest coverage ratio | n/a |
| Cash | US$104.30m |
| Equity | US$760.00m |
| Total liabilities | US$350.50m |
| Total assets | US$1.11b |
Recent financial health updates
Does Myriad Genetics (NASDAQ:MYGN) Have A Healthy Balance Sheet?
Mar 28
Is Myriad Genetics (NASDAQ:MYGN) Using Debt Sensibly?
Aug 07Recent updates
Is Myriad Genetics, Inc. (NASDAQ:MYGN) Trading At A 33% Discount?
Jun 05Myriad Genetics, Inc.'s (NASDAQ:MYGN) Price Is Right But Growth Is Lacking After Shares Rocket 26%
May 11Analysts Have Made A Financial Statement On Myriad Genetics, Inc.'s (NASDAQ:MYGN) First-Quarter Report
May 09Does Myriad Genetics (NASDAQ:MYGN) Have A Healthy Balance Sheet?
Mar 28An Intrinsic Calculation For Myriad Genetics, Inc. (NASDAQ:MYGN) Suggests It's 37% Undervalued
Feb 02Myriad Genetics' Strategic Growth Fuels Bullish Outlook
Jan 31Revenues Working Against Myriad Genetics, Inc.'s (NASDAQ:MYGN) Share Price
Dec 18Is Myriad Genetics (NASDAQ:MYGN) Using Debt Sensibly?
Aug 07Calculating The Intrinsic Value Of Myriad Genetics, Inc. (NASDAQ:MYGN)
Apr 13Myriad: Trying To Find Its Footing In An Evolving Industry
Sep 26Myriad Genetics receives expanded coverage in Japan for breast cancer diagnostic system
Aug 25Are Investors Undervaluing Myriad Genetics, Inc. (NASDAQ:MYGN) By 50%?
Aug 05Myriad Genetics Q2 2022 Earnings Preview
Aug 03Myriad Genetics touts study results of GeneSight test on depression remission rates
Jul 12Financial Position Analysis
Short Term Liabilities: MYGN's short term assets ($290.3M) exceed its short term liabilities ($146.1M).
Long Term Liabilities: MYGN's short term assets ($290.3M) exceed its long term liabilities ($204.4M).
Debt to Equity History and Analysis
Debt Level: MYGN has more cash than its total debt.
Reducing Debt: MYGN's debt to equity ratio has reduced from 24.4% to 5.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MYGN has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if MYGN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.